24 patent families filed as EX-IX opens its marketplace

EX-IX opened its patent liquidity marketplace this month with 24 families filed, 100 more in the pipeline, and a new asset class: tradable fractional rights to industrial-grade patent portfolios. The thesis: originate patents at industrial cadence, validate through simulation before filing, tokenize economic rights for investment. If it works, it creates something that does not exist anywhere — a liquid secondary market for patent value.

The Problem

Patents are the most valuable illiquid asset class in the world. WIPO estimates intangible assets hit almost $80 trillion in 2024. Licensing generates $200-500 billion annually. There is no secondary market for any of it.

Equities have exchanges. Bonds have clearinghouses. Real estate has REITs. Patents have nothing. The existing infrastructure is a patchwork of boutique brokerages and directory listings. None provide scalable liquidity.

IPXI raised $5.5 million, built an SEC-regulated exchange, and collapsed within 24 months. Blockchain attempts followed — IPwe, Nodalblock — none reached scale. Three problems killed them and still exist:

• Origination. Most patents are filed reactively, not as part of a systematic portfolio build. No one is building patent supply at industrial scale.
• Validation. No standard mechanism tests technical substance before filing. After filing, an 18-month publication window keeps investors blind.
• Liquidity. Patent value is locked inside bilateral deals or litigation. You cannot buy or sell a fraction of future revenue without a custom legal contract.

The Mechanism

EX-IX has two sides: a patent factory and a tokenization marketplace.

The factory files in coordinated batches. First run: 24 families in women's health wearables for Edge Assist, a whitespace with only 24 existing patents in the entire field. Before filing, every candidate goes through a physics-grade digital twin simulation. The Edge Assist thermal twin hit 0.76% MAPE against physical test data.

Once filed, economic rights tokenize. Value follows a four-stage curve:

• Filed — priority locked, claims untested
• Examination — independent claims survive, substance confirmed
• Grant — first jurisdiction allows, enforceable right
• Global — US + EU + China granted, full rights stack

Each stage reveals more information. A granted patent in one jurisdiction is worth more than a filed patent in three.

Beyond the first 24: roughly 100 more validated in the pipeline. Five upcoming from Energaia Institute Ltd covering catalytic gas cleaning, syngas conditioning, and clean energy technologies.

Market Opportunity

The intermediated patent transaction market is $2-5 billion annually. The opportunity is not capturing share of that — it is creating a new category: liquid, fractional patent investment.

If 0.5% of the $200-500 billion licensing pool moves through a tokenized marketplace, that is $1-2.5 billion in volume. And liquid markets expand the addressable pool — investors who never considered patent exposure can enter at fractional levels.

Competitors tell the story. IAM Market is a directory with no valuation or tokenization. yet2.com is high-touch consulting. Ocean Tomo has done $10 billion in cumulative transactions but every deal is bespoke. None combine origination, validation, and marketplace.

The barrier is investor education. EX-IX mitigates it by starting with its own originated patents. A buyer should watch the first six months of office actions — the examiner's response to the first 24 families is the first real quality signal.

Patent Angle

Edge Assist (EXIX001) is the inaugural family: hardware-signed, tamper-proof audit trails for AI decisions on edge devices. Application P00202606645, dual US/EU prosecution underway.

Four elements define the strategy:

• Claim scope. Hardware-signature binding, not software. Grounds claims in physical structure, harder to design around, less vulnerable to Alice challenges.
• Regulatory alignment. EU AI Act Article 12 mandates audit trail traceability. The patents claim the infrastructure, not the compliance process — value from regulation without depending on any single regulation surviving court.
• Whitespace. Patent density analysis found only 24 existing patents in the entire women's health wearables field. Limited prior art for the examiner to cite.
• Geography. US courts (jury trials, higher damages) and EPO (regulatory enforcement under EU AI Act) simultaneously. The EPO received 199,775 applications in 2024 — computer tech at 16,833 filings, electrical machinery at 15,853, medical tech at 14,922 — all intersecting EX-IX's pipeline.

Most filers optimize for allowance speed. EX-IX optimizes for claim robustness and market relevance, accepting longer prosecution for stronger, more defensible patents.

Long-Term Prospects

The trajectory depends on three variables.

First, prosecution outcomes. Industry norm is 50-60% independent claim survival through first office action. EX-IX's actual rate on the first 24 families over the next 12-18 months will be the first quality data point.

Second, regulation. EU AI Act enforcement runs 2027-2030. Delayed or diluted enforcement weakens the tailwind. Acceleration compresses the timeline for Edge Assist.

Third, marketplace liquidity. Phase 1 uses EX-IX's own patents. Phase 2 opens to third-party IP. The transition requires trading volume on Phase 1, price-discovery function, and regulatory clarity on tokenized securities.

The asymmetric bet is the 100+ patent pipeline in clean energy. If even a fraction grant with defensible claims and a carbon pricing regime materializes, the portfolio re-rates.

Downside: patent examination is unpredictable. Tokenization of patent rights has not been tested at scale. And the history of patent marketplaces is a graveyard of failed attempts — IPXI, IPwe, Nodalblock. EX-IX works only if it solves the problems that killed every predecessor.

Conclusion

EX-IX opens into a $200-500 billion licensing market with no existing liquidity infrastructure. It has 24 families filed, 100 more validated, a validation methodology at 0.76% MAPE, and a tokenization structure for fractional investment.

The thesis is falsifiable. If prosecution rates fall below norms, if tokenization adoption fails, if regulatory tailwinds reverse, or if patent markets prove structurally resistant to commoditization — the model does not work.

If it works, EX-IX has built something that does not exist: a liquid secondary market for patent value, integrated end-to-end with an industrial-scale origination factory. The data arrives over the next 12-18 months as the first office actions come in.

---

Verification: $80 trillion intangible assets (WIPO PR/2025/936, DG Daren Tang). 199,775 EPO applications 2024, 16,833 computer tech / 15,853 elec machinery / 14,922 medical tech (EPO Patent Index 2025). $200-500B licensing market (Ocean Tomo, ktMINE, WIPO surveys). 24 families filed, 100+ pipeline, 0.76% MAPE (EX-IX homepage). 5 Energaia patents (vault). IPXI $5.5M, 24-month collapse (vault). Ocean Tomo $10B+ (vault). All claims traceable.